Jade Biosciences, Inc.
JBIONASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $890.91M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $8.36$28.00
- Volume (live)
- -
- Avg. volume (3M)
- 996.94K
Jade Biosciences (JBIO) Stock Price & Financial Analysis
Jade Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $14.54 - $15.00 |
|---|---|
| 52-Week High | $28.00 |
| 52-Week Low | $8.36 |
| Open | $14.89 |
| Volume (last close) | 634.37K |
| Average Volume (3M) | 996.94K |
| 50-Day MA | $17.85 |
|---|---|
| 200-Day MA | $18.20 |
| 1-Year Change | +50.15% |
| Market Cap | 890.91M |
|---|---|
| Shares Outstanding | 61.06M |
| Price to Book (P/B) | 2.03 |
| EV/EBITDA | -4.97 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Apr 29, 2025 |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Jade Biosciences at a Glance
As of the Oct 23, 2026 close, Jade Biosciences (JBIO) has a market capitalization of $890.91M.
As of its latest reported balance sheet, it holds $107.25M in cash and securities against $628.00K of debt, a net cash position of $106.62M.
Jade Biosciences does not currently pay a dividend.
The share price is up 50.2% over the past year. At $14.59 (the Oct 23, 2026 close) it sits within its 52-week range of $8.36 to $28.00, below its 200-day moving average of $18.20.
Based on 10 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $50.50, 246.1% above the Oct 23, 2026 close.
Frequently Asked Questions About Jade Biosciences
What is the current stock price for JBIO?
As of the Oct 23, 2026 close, JBIO stock trades at $14.59. The 52-week range is $8.36–$28.00, with a day range of $14.54–$15.00.
What is the P/E ratio for JBIO?
The P/E ratio (Price-to-Earnings) for JBIO is shown in the Key Statistics section. This valuation metric helps compare Jade Biosciences, Inc. to industry peers.
Does JBIO pay dividends?
Jade Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for JBIO?
Based on ratings from 10 professional analysts over the last 90 days, the consensus for JBIO is Buy. The average 12-month price target is $50.50, a 246.1% upside from the Oct 23, 2026 close of $14.59.
What is the market cap of JBIO?
As of the Oct 23, 2026 close, Jade Biosciences's market capitalization is $890.9M, classifying it as a small-cap company. Jade Biosciences operates in the Healthcare sector within the Biotechnology industry.